Fort Dodge Laboratories Inc. is recalling approximately 9,107 jars of Nolvasan Antiseptic Ointment (1% Chlorhexidine acetate) because the product failed quality testing during a 15-month stability check. This failure, known as an out-of-specification assay result, means the medication may not maintain the correct concentration of its active ingredient over time. The recalled product is an antiseptic ointment for animals packaged in 16-ounce jars and was distributed nationwide to wholesale accounts.
When the concentration of an active ingredient like Chlorhexidine acetate falls below the required levels, the ointment may lose its effectiveness in treating or preventing infections. Using a sub-potent antiseptic can lead to untreated veterinary conditions or the development of more serious infections in animals.
Contact healthcare provider and return product for refund.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response